N (6)-substituted AMPs inhibit mammalian deoxynucleotide N-hydrolase DNPH1

PLoS One. 2013 Nov 19;8(11):e80755. doi: 10.1371/journal.pone.0080755. eCollection 2013.

Abstract

The gene dnph1 (or rcl) encodes a hydrolase that cleaves the 2'-deoxyribonucleoside 5'-monophosphate (dNMP) N-glycosidic bond to yield a free nucleobase and 2-deoxyribose 5-phosphate. Recently, the crystal structure of rat DNPH1, a potential target for anti-cancer therapies, suggested that various analogs of AMP may inhibit this enzyme. From this result, we asked whether N (6)-substituted AMPs, and among them, cytotoxic cytokinin riboside 5'-monophosphates, may inhibit DNPH1. Here, we characterized the structural and thermodynamic aspects of the interactions of these various analogs with DNPH1. Our results indicate that DNPH1 is inhibited by cytotoxic cytokinins at concentrations that inhibit cell growth.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine Monophosphate / analogs & derivatives
  • Adenosine Monophosphate / chemistry
  • Adenosine Monophosphate / metabolism
  • Adenosine Monophosphate / pharmacology*
  • Amino Acid Sequence
  • Animals
  • Catalytic Domain
  • Enzyme Activation / drug effects
  • Humans
  • Kinetics
  • Models, Molecular
  • Molecular Conformation
  • Molecular Sequence Data
  • N-Glycosyl Hydrolases / chemistry
  • N-Glycosyl Hydrolases / genetics
  • N-Glycosyl Hydrolases / metabolism*
  • Nuclear Proteins / chemistry
  • Nuclear Proteins / genetics
  • Nuclear Proteins / metabolism*
  • Protein Binding
  • Proto-Oncogene Proteins / chemistry
  • Proto-Oncogene Proteins / genetics
  • Proto-Oncogene Proteins / metabolism*
  • Rats
  • Sequence Alignment
  • Thermodynamics

Substances

  • Nuclear Proteins
  • Proto-Oncogene Proteins
  • Adenosine Monophosphate
  • DNPH1 protein, human
  • DNPH1 protein, rat
  • N-Glycosyl Hydrolases

Grants and funding

This work was financially supported by the Institut Pasteur, CNRS, Fondation pour la Recherche Medicale (DCM20111223063 to S. Pochet) and by the French Infrastructure for Integrated Structural Biology (FRISBI) ANR-10-INSB-05-01. C. Amiable was recipient of a fellowship from the French Ministry of Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.